Bruker (BRKR) Asset Writedowns and Impairment (2010 - 2026)
Bruker's (BRKR) quarterly Asset Writedowns and Impairment came in at $4.8 million in Q4 2025, up 380.0% YoY from $1000000.0 in Q4 2024, and up 380.0% on a QoQ basis from $1.0 million in Q4 2024.
Bruker (BRKR) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
Bruker (BRKR) has 13 years of Asset Writedowns and Impairment data on file, last reported at $4.8 million in Q4 2025.
- Quarterly Asset Writedowns and Impairment rose 380.0% year-over-year to $4.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $26.0 million (up 15.04% YoY) and the FY2025 annual result came in at $152.3 million, up 434.39% from the prior year.
- Asset Writedowns and Impairment advanced to $4.8 million in Q4 2025, from $1.0 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $20.2 million in Q2 2024 to a low of -$1.9 million in Q3 2022.
- A 4-year average of $4.5 million and a median of $2.0 million in 2022 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment surged 11500.0% — and 2024, when it slumped 79.71%.
- Tracing BRKR's Asset Writedowns and Impairment over 4 years: stood at $1.6 million in 2022, then jumped by 68.75% to $2.7 million in 2023, then plunged by 62.96% to $1.0 million in 2024, then soared by 380.0% to $4.8 million in 2025.
- The last three Asset Writedowns and Impairment figures came in at $4.8 million (Q4 2025), $1.0 million (Q4 2024), and $20.2 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Bruker | 9.13 Bn | 9.13 Bn | 416.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.10 Mn |
| Jun 30, 2026 | 4.10 Mn |
| Dec 31, 2025 | 4.80 Mn |
| Dec 31, 2025 | 4.80 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Jun 30, 2024 | 20.20 Mn |
| Jun 30, 2024 | 20.20 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Dec 31, 2023 | 2.70 Mn |
| Dec 31, 2023 | 2.70 Mn |
| Jun 30, 2023 | 11.40 Mn |
| Jun 30, 2023 | 11.40 Mn |
| Mar 31, 2023 | 6.90 Mn |
| Mar 31, 2023 | 6.90 Mn |
| Dec 31, 2022 | 1.60 Mn |
| Dec 31, 2022 | 1.60 Mn |
| Sep 30, 2022 | -1.90 Mn |
| Sep 30, 2022 | -1.90 Mn |